Y-Box Binding Protein-1 Down-Regulates Expression of Carbamoyl Phosphate Synthetase-I by Suppressing CCAAT Enhancer-Binding Protein-Alpha Function in Mice

Gastroenterology

Volumn 137, Issue 1, 2009, Pages 330-340

  Chen, Yen Rong ^a   Sekine, Keisuke ^b   Nakamura, Koji ^c   Yanai, Hiroyuki ^c   Tanaka, Minoru ^a   Miyajima, Atsushi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b MEIKAI UNIVERSITY SCHOOL OF DENTISTRY   (Japan)

^c LivTech   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; CARBAMOYL PHOSPHATE SYNTHASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; LUCIFERASE; Y BOX BINDING PROTEIN 1;

AMMONIA BLOOD LEVEL; ANIMAL CELL; ARTICLE; BINDING SITE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DETOXIFICATION; DOWN REGULATION; ENZYME ASSAY; FETUS; FETUS LIVER; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LIVER CELL CULTURE; LIVER INJURY; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; TRANSCRIPTION INITIATION; UPREGULATION;

EID: 67649207652     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.02.064     Document Type: Article

References (36)

1. Gropman A.L., and Batshaw M.L. Cognitive outcome in urea cycle disorders. Mol Genet Metab 81 Suppl 1 (2004) S58-S62
2. Takeoka M., Soman T.B., Shih V.E., et al. Carbamyl phosphate synthetase 1 deficiency: a destructive encephalopathy. Pediatr Neurol 24 (2001) 193-199
3. Gelehrter T.D., and Snodgrass P.J. Lethal neonatal deficiency of carbamyl phosphate synthetase. N Engl J Med 290 (1974) 430-433
4. Schofield J.P., Cox T.M., Caskey C.T., et al. Mice deficient in the urea-cycle enzyme, carbamoyl phosphate synthetase I, die during the early neonatal period from hyperammonemia. Hepatology 29 (1999) 181-185
5. Christoffels V.M., Grange T., Kaestner K.H., et al. Glucocorticoid receptor, C/EBP, HNF3, and protein kinase A coordinately activate the glucocorticoid response unit of the carbamoylphosphate synthetase I gene. Mol Cell Biol 18 (1998) 6305-6315
6. Christoffels V.M., van den Hoff M.J., Moorman A.F., et al. The far-upstream enhancer of the carbamoyl-phosphate synthetase I gene is responsible for the tissue specificity and hormone inducibility of its expression. J Biol Chem 270 (1995) 24932-24940
7. Hoogenkamp M., Stallen J.M., Lamers W.H., et al. In vivo footprinting of the carbamoylphosphate synthetase I cAMP-response unit indicates important roles for FoxA and PKA in formation of the enhanceosome. Biochimie 88 (2006) 1357-1366
8. Schoneveld O.J., Gaemers I.C., Hoogenkamp M., et al. The role of proximal-enhancer elements in the glucocorticoid regulation of carbamoylphosphate synthetase gene transcription from the upstream response unit. Biochimie 87 (2005) 1033-1040
9. Kimura T., Christoffels V.M., Chowdhury S., et al. Hypoglycemia-associated hyperammonemia caused by impaired expression of ornithine cycle enzyme genes in C/EBPalpha knockout mice. J Biol Chem 273 (1998) 27505-27510
10. Matsumoto K., and Wolffe A.P. Gene regulation by Y-box proteins: coupling control of transcription and translation. Trends Cell Biol 8 (1998) 318-323
11. Didier D.K., Schiffenbauer J., Woulfe S.L., et al. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc Natl Acad Sci U S A 85 (1988) 7322-7326
12. Evdokimova V., Ovchinnikov L.P., and Sorensen P.H. Y-box binding protein 1: providing a new angle on translational regulation. Cell Cycle 5 (2006) 1143-1147
13. Ise T., Nagatani G., Imamura T., et al. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen. Cancer Res 59 (1999) 342-346
14. Kohno K., Izumi H., Uchiumi T., et al. The pleiotropic functions of the Y-box-binding protein, YB-1. Bioessays 25 (2003) 691-698
15. Yasen M., Kajino K., Kano S., et al. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma. Clin Cancer Res 11 (2005) 7354-7361
16. Inagaki Y., Kushida M., Higashi K., et al. Cell type-specific intervention of transforming growth factor beta/Smad signaling suppresses collagen gene expression and hepatic fibrosis in mice. Gastroenterology 129 (2005) 259-268
17. Lu Z.H., Books J.T., and Ley T.J. YB-1 is important for late-stage embryonic development, optimal cellular stress responses, and the prevention of premature senescence. Mol Cell Biol 25 (2005) 4625-4637
18. Kamiya A., Kinoshita T., Ito Y., et al. Fetal liver development requires a paracrine action of oncostatin M through the gp130 signal transducer. EMBO J 18 (1999) 2127-2136
19. Tanimizu N., Nishikawa M., Saito H., et al. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci 116 (2003) 1775-1786
20. Lee Y.H., Sauer B., Johnson P.F., et al. Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol 17 (1997) 6014-6022
21. Sekine K., Chen Y.R., Kojima N., et al. Foxo1 links insulin signaling to C/EBPalpha and regulates gluconeogenesis during liver development. EMBO J 26 (2007) 3607-3615
22. Nakamura K., Nonaka H., Saito H., et al. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39 (2004) 635-644
23. Kojima N., Kinoshita T., Kamiya A., et al. Cell density-dependent regulation of hepatic development by a gp130-independent pathway. Biochem Biophys Res Commun 277 (2000) 152-158
24. Tanimizu N., and Miyajima A. Molecular mechanism of liver development and regeneration. Int Rev Cytol 259 (2007) 1-48
25. Jurchott K., Bergmann S., Stein U., et al. YB-1 as a cell cycle-regulated transcription factor facilitating cyclin A and cyclin B1 gene expression. J Biol Chem 278 (2003) 27988-27996
26. Lagace M., Goping I.S., Mueller C.R., et al. The carbamyl phosphate synthetase promoter contains multiple binding sites for C/EBP-related proteins. Gene 118 (1992) 231-238
27. Meijer A.J., Lamers W.H., and Chamuleau R.A. Nitrogen metabolism and ornithine cycle function. Physiol Rev 70 (1990) 701-748
28. Gupta S., Rogers L.K., Taylor S.K., et al. Inhibition of carbamyl phosphate synthetase-I and glutamine synthetase by hepatotoxic doses of acetaminophen in mice. Toxicol Appl Pharmacol 146 (1997) 317-327
29. Bargou R.C., Jurchott K., Wagener C., et al. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med 3 (1997) 447-450
30. Goping I.S., and Shore G.C. Interactions between repressor and anti-repressor elements in the carbamyl phosphate synthetase I promoter. J Biol Chem 269 (1994) 3891-3896
31. Subramanian L., Benson M.D., and Iniguez-Lluhi J.A. A synergy control motif within the attenuator domain of CCAAT/enhancer-binding protein alpha inhibits transcriptional synergy through its PIASy-enhanced modification by SUMO-1 or SUMO-3. J Biol Chem 278 (2003) 9134-9141
32. Grant C.E., and Deeley R.G. Cloning and characterization of chicken YB-1: regulation of expression in the liver. Mol Cell Biol 13 (1993) 4186-4196
33. Uramoto H., Izumi H., Ise T., et al. p73 Interacts with c-Myc to regulate Y-box-binding protein-1 expression. J Biol Chem 277 (2002) 31694-31702
34. Shirota Y., Kaneko S., Honda M., et al. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 33 (2001) 832-840
35. Schmiedeberg P., Biempica L., and Czaja M.J. Timing of protooncogene expression varies in toxin-induced liver regeneration. J Cell Physiol 154 (1993) 294-300
36. Fukada T., and Tonks N.K. Identification of YB-1 as a regulator of PTP1B expression: implications for regulation of insulin and cytokine signaling. EMBO J 22 (2003) 479-493